{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:46:26Z","timestamp":1783813586906,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.clinthera.2005.07.011","type":"journal-article","created":{"date-parts":[[2005,9,10]],"date-time":"2005-09-10T07:39:42Z","timestamp":1126337982000},"page":"979-992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Giovanni","family":"Passalacqua,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica,","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.07.011_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1398-9995.2002.1r3542.x","article-title":"The role of histamine in allergic disease: Reappraisal of its inflammatory potential","volume":"57","author":"Bachert","year":"2002","journal-title":"Allergy."},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2005.07.011_bib2","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0091-6749(03)01881-5","article-title":"The histaminecytokine network in allergic inflammation","volume":"112","author":"Marone","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mai.2003.1585","article-title":"Histamine in the immune regulation of allergic inflammation","volume":"112","author":"Akdis","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.0954-7894.2002.01314.x","article-title":"H1-antihistamines: Inverse agonism, anti-inflammatory actions and cardiac effects","volume":"32","author":"Leurs","year":"2002","journal-title":"Clin Exp Allergy."},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2005.07.011_bib5","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0091-6749(03)01877-3","article-title":"Histamine: A mediator of inflammation","volume":"112","author":"MacGlashan","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1365-2222.2003.01769.x","article-title":"Consensus Group on New-Generation Antihistamines (CONGA): Present status and recommendations","volume":"33","author":"Holgate","year":"2003","journal-title":"Clin Exp Allergy."},{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2005.07.011_bib7","first-page":"S220","article-title":"Allergic rhinitis and its impact on asthma","volume":"105","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.2001.04175.x","article-title":"Management and diagnostic guidelines for urticaria and angio-oedema","volume":"144","author":"Grattan","year":"2001","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mai.2003.168","article-title":"Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis","volume":"111","author":"Simons","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1067\/mai.2002.124657","article-title":"Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen- induced allergic rhinitis in an allergen-exposure unit","volume":"109","author":"Horak","year":"2002","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mjd.2003.143","article-title":"Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial","volume":"48","author":"Monroe","year":"2003","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1398-9995.2003.00171.x","article-title":"Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites","volume":"58","author":"Potter","year":"2003","journal-title":"Allergy."},{"key":"10.1016\/j.clinthera.2005.07.011_bib13","first-page":"305","article-title":"Efficacy and safety of levocetirizine in seasonal allergic rhinitis","volume":"55","author":"Leynadier","year":"2001","journal-title":"Acta Otorhinolaryngol Belg."},{"key":"10.1016\/j.clinthera.2005.07.011_bib14","first-page":"632","article-title":"Chronic urticaria: Clinical aspects and focuson a new antihistamine, levocetirizine","volume":"3","author":"Kapp","year":"2004","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/jm9704311","article-title":"Molecular properties and pharmacokinetic behaviour of cetirizine, a zwitterionic H 1-receptor antagonist","volume":"41","author":"Pagliara","year":"1998","journal-title":"J Med Chem."},{"key":"10.1016\/j.clinthera.2005.07.011_bib16","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2165\/00003495-200363190-00010","article-title":"Desloratidine: An update of its efficacy in the management of allergic disorders","volume":"63","author":"Murdoch","year":"2003","journal-title":"Drugs."},{"key":"10.1016\/j.clinthera.2005.07.011_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s002280100364","article-title":"Absorption, distribution, metabolism and excretion of [14C] levocetirizine, the Renantiomer of cetirizine, in healthy volunteers","volume":"57","author":"Benedetti","year":"2001","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0006-2952(03)00558-6","article-title":"Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonists","volume":"66","author":"Tillement","year":"2003","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1472-8206.2004.00254.x","article-title":"Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine, and mizolastine in humans","volume":"18","author":"Molimard","year":"2004","journal-title":"Fundam Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1529-8019.2000.00041.x","article-title":"The apparent volumes of distribution of H1-receptor antagonists","volume":"13","author":"Tillement","year":"2000","journal-title":"Dermatol Ther."},{"issue":"Suppl 9A","key":"10.1016\/j.clinthera.2005.07.011_bib21","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1016\/S0002-9343(02)01436-5","article-title":"Comparative pharmacology of H1 antihistamines: Clinical relevance","volume":"113","author":"Simons","year":"2002","journal-title":"Am J Med."},{"key":"10.1016\/j.clinthera.2005.07.011_bib22","first-page":"391","article-title":"Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: Contribution of Lys(191) and Thr(194)","volume":"61","author":"Gillard","year":"2002","journal-title":"Mol Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.07.011_bib23","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s000110300050","article-title":"H1 antagonists: Receptor affinity versus selectivity","volume":"52","author":"Gillard","year":"2003","journal-title":"Inflamm Res."},{"key":"10.1016\/j.clinthera.2005.07.011_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2222.2004.1904.x","article-title":"Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis","volume":"34","author":"Lee","year":"2004","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.clinthera.2005.07.011_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00011-003-1193-5","article-title":"Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin","volume":"52","author":"Denham","year":"2003","journal-title":"Inflamm Res."},{"key":"10.1016\/j.clinthera.2005.07.011_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-2125.2003.01897.x","article-title":"Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin","volume":"56","author":"Purohit","year":"2003","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1368-5031.2004.0117.x","article-title":"Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU)","volume":"58","author":"Day","year":"2004","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.clinthera.2005.07.011_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2004.01.773","article-title":"Levocetirizine better protects than desloratadine in a nasal provocation with allergen","volume":"113","author":"Deruaz","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1365-2222.2004.01960.x","article-title":"Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: A pilot study","volume":"34","author":"Ciprandi","year":"2004","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.clinthera.2005.07.011_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000080657","article-title":"Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours","volume":"135","author":"Passalacqua","year":"2004","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib31","series-title":"22nd Congress of the European Academy of Allergy and Clinical Immunology","article-title":"Levocetirizine but not desloratadine inhibits histamine-induced changes in nasal temperature measured by facial thermography: A pilot study.","author":"Larbig","year":"2003"},{"key":"10.1016\/j.clinthera.2005.07.011_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1398-9995.1993.tb02399.x","article-title":"Facial thermography during nasal provocation tests with histamine and allergen","volume":"48","author":"Seppey","year":"1993","journal-title":"Allergy."},{"key":"10.1016\/j.clinthera.2005.07.011_bib33","series-title":"Xyzal [package insert]","year":"2003"},{"key":"10.1016\/j.clinthera.2005.07.011_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2002.01611.x","article-title":"Lack of effect of single and repeated dosesof levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers","volume":"54","author":"Gandon","year":"2002","journal-title":"BrJ Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/0300799019117011","article-title":"The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and wheal and flare","volume":"17","author":"Hindmarch","year":"2001","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.clinthera.2005.07.011_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mai.2003.63","article-title":"Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood","volume":"111","author":"Verster","year":"2003","journal-title":"J Allergy Clin Immunol."},{"issue":"Suppl 48","key":"10.1016\/j.clinthera.2005.07.011_bib37","first-page":"164s","article-title":"Levocetirizine for SAR and PAR in children","volume":"24","author":"de Blic","year":"2004","journal-title":"EurRespir J."},{"key":"10.1016\/j.clinthera.2005.07.011_bib38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2004.05.070","article-title":"Levocetirizine improves quality of life and reduces costsin long-term management of persistent allergic rhinitis","volume":"114","author":"Bachert","year":"2004","journal-title":"J Allergy Clin Immunol."},{"issue":"Suppl 75","key":"10.1016\/j.clinthera.2005.07.011_bib39","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1034\/j.1398-9995.57.s75.3.x","article-title":"Therapeutic points of intervention and clinical implications: Role of desloratadine","volume":"57","author":"Bachert","year":"2002","journal-title":"Allergy."},{"key":"10.1016\/j.clinthera.2005.07.011_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000070218","article-title":"Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma","volume":"130","author":"Baena-Cagnani","year":"2003","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2125.2004.02110.x","article-title":"Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma","volume":"58","author":"Lee","year":"2004","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2005.07.011_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jaci.2004.01.741","article-title":"Advances in upper airway diseases and allergen immunotherapy","volume":"113","author":"Nelson","year":"2004","journal-title":"J Allergy Clin Immunol."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:47:13Z","timestamp":1758962833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0149291805001347"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.07.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}